Skip to content
Emergency:0761 1301-2200
Evangelisches Diakoniekrankenhaus Freiburg
Central Emergency Department24/7 · Life-threatening: 112

Studies

As part of our Gynaecological Cancer Centre, we conduct studies, about which we would like to inform you here.

SMARAGD

The SMARAGD study is a registry platform that prospectively records patients with advanced ovarian and endometrial cancer in order to reflect the reality of treatment in Germany. Here we cooperate with the practice for haematology and oncology, which initiated this study.

Should I take part in a clinical study?

On the website Patienten-Information.de, a service of the German Medical Association (Bundesärztekammer), you will find all the important information you need to decide whether to take part in a study.

Last updated:

Finder